title: Tio2-dopamine complex implanted unilaterally in the caudate nucleus improves motor activity and behavior function of rats with induced hemiparkinsonism.
abstract: Parkinson's disease (PD) is characterized by malfunction of dopaminergic systems, and the current symptomatic treatment is to replace lost dopamine. For investigating mechanisms of pathogenesis and alternative treatments to compensate lack of dopamine (DA) activity in PD, the 6-hydroxydopamine (6-OHDA)-lesioned rat model of PD has been useful, these animals display apomorphine-induced contralateral rotational behavior, when they are examined after lesion. The purpose of this study was to assess Titania-dopamine (TiO2-DA) complexes implanted on the caudate nucleus for diminishing motor behavior alterations of the 6-OHDA rat model. Rats with 6-OHDA unilateral lesions received TiO2 alone or TiO2-DA implants, and were tested for open field (OF) gross motor crossing and rearing behaviors, and apomorphine-induced rotation (G) behavior. TiO2 complex have no effects on rearing OF and G behaviors, and a significant reducing effect on crossing motor behavior of normal rats compared to control non-treated rats throughout 56 days of observation. Interestingly, TiO2-DA treatment significant recovered motor crossing and rearing behaviors in 6-OHDA-lesioned rats, and diminished the G behaviors during 56 days of examination. Additionally, in the 6-OHDA-lesioned rats TiO2 treatment had a moderate recovering effect only on crossing behavior compared to lesioned non treated rats. Our results suggest that continuous release of dopamine in the caudate nucleus from TiO2-DA complex is capable of reversing gross motor deficits observed in the 6-OHDA-lesioned rat model of PD. Thistype of delivery system of DA represents a promising therapy for PD in humans.
authors.affiliation: Dept. Physiol., Physics Institute, Natl. Autonomic Univ. México.
authors.forename: Patricia
authors.initials: P
authors.lastname: Vergara-Aragón
authors.forename: Leonardo Eduardo
authors.initials: LE
authors.lastname: Domínguez-Marrufo
authors.forename: Patricia
authors.initials: P
authors.lastname: Ibarra-Guerrero
authors.forename: Heidi
authors.initials: H
authors.lastname: Hernandez-Ramírez
authors.forename: Beatriz
authors.initials: B
authors.lastname: Hernández-Téllez
authors.forename: Irma Elena
authors.initials: IE
authors.lastname: López-Martínez
authors.forename: Ivonne
authors.initials: I
authors.lastname: Sánchez-Cervantes
authors.forename: Patricia
authors.initials: P
authors.lastname: Santiago-Jacinto
authors.forename: Jorge Alberto
authors.initials: JA
authors.lastname: García-Macedo
authors.forename: Guadalupe
authors.initials: G
authors.lastname: Valverde-Aguilar
authors.forename: Julio
authors.initials: J
authors.lastname: Santiago
mesh_terms: D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000502:physiology*; D004298:Dopamine / Q000008:administration & dosage*; D008297:Male; D009043:Motor Activity; D020734:Parkinsonian Disorders / Q000503:physiopathology / Q000628:therapy*; D051381:Rats; D017208:Rats, Wistar; D012399:Rotation; D014025:Titanium / Q000008:administration & dosage*
chemical_list: C009495:titanium dioxide; D014025:Titanium; D001058:Apomorphine; D004298:Dopamine